Dallah Healthcare completes Care Shield acquisition
Argaam
24/12/2025
| Last Trade | 120.70 |
| Change | (0.90) |
| Change (%) | (0.74) |
| Open | 121.70 |
| Low | 120.70 |
| High | 122.70 |
| Prev. Close | 121.60 |
| Change (3M) | (19.53 %) |
| Change (6M) | (11.25 %) |
| Volume | 95,614 |
| Turnover | 11,634,497.00 |
| Transactions | 1,145 |
| Market Value | 12,260.10 |
| Avg. Volume (3M) | 67,453.47 |
| Avg. Turnover (3M) | 8,643,575.30 |
| Avg. Transaction (3M) | 1,342.55 |
| Change (12M) | (23.41 %) |
| YTD | (3.82 %) |
|
Event Date
|
Event
|
||
|---|---|---|---|
|
30-11-2025
|
Cash Dividend Distribution | ||
|
10-11-2025
|
Ex-dividend Date | ||
|
19-10-2025
|
General Assembly | ||
|
04-09-2025
|
Cash Dividend Distribution | ||
|
17-08-2025
|
Ex-dividend Date | ||
| More | |||
| Report | Interim | Year |
| Dallah earns SAR 421.7M in 9M 2025, SAR 141.9M in Q3 | 9 M | 2025 |
| Dallah H1 2025 profit up 21% to SAR 279.8M; Q2 at SAR 124.3M | 6 M | 2025 |
| Dallah profit jumps 30% to SAR 155.6M in Q1 2025 | 3 M | 2025 |
| Dallah’s profit rises 31% to SAR 471.2M in 2024; Q4 at SAR 113.9M | 12 M | 2024 |
| Date | Research firm | Rating |
|
|
AlphaMena | Underweight |
|
|
U-Capital | Hold |
|
|
AlJazira Capital | Neutral |
|
|
EFG-Hermes | Buy |
